IGC Pharma, Inc. (IGC) ownership: Top institutional holder: VANGUARD GROUP INC ($322945.00). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| VANGUARD GROUP INC | 1149268.00 | $322945.00 | 2025-12-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 1043384.00 | $274440.00 | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 718436.00 | $188949.00 | 2026-03-31 |
| BlackRock, Inc. | 703798.00 | $185099.00 | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 483975.00 | $127285.00 | 2026-03-31 |
| VANGUARD FIDUCIARY TRUST CO | 415888.00 | $109379.00 | 2026-03-31 |
| CITADEL ADVISORS LLC | 277594.00 | $78115.00 | 2025-12-31 |
| STATE STREET CORP | 200799.00 | $52810.00 | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-30 | |
| Sell | null | 2026-06-30 | |
| Sell | null | 2026-04-01 | |
| Sell | null | 2026-04-01 | |
| Sell | null | 2026-04-01 | |
| Sell | null | 2026-04-01 | |
| Sell | null | 2026-04-01 | |
| Sell | null | 2026-04-01 |
Back to IGC overview · IGC earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.